Massimo Fiandaca
Executive Vice President, Therapeutic Strategies at Asklepios BioPharmaceutical, Inc. (AskBio) - CNS Gene Therapy | Castro Valley, California, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Massimo Fiandaca serves as the Executive Vice President of Therapeutic Strategies at Asklepios BioPharmaceutical, Inc. (AskBio), where he leverages his extensive background in neurosurgery and neuroscience to drive the development of innovative gene therapies for central nervous system (CNS) disorders. With a robust foundation in both academic and private practice settings, Massimo's expertise encompasses a wide range of therapeutic strategies aimed at addressing the complexities of neurological diseases. His current focus involves the strategic coordination and execution of direct brain delivery therapies, utilizing advanced methodologies and devices to enhance therapeutic efficacy.
At AskBio, now part of Bayer, Massimo is instrumental in the planning and administration of clinical trials, ensuring rigorous safety monitoring and compliance with regulatory standards. His entrepreneurial spirit and strategic development experience enable him to navigate the intricate landscape of biotechnology, fostering collaborations that propel drug discovery and development forward. Massimo’s work emphasizes the importance of biomarkers in the therapeutic process, as well as the integration of cutting-edge technologies such as convection-enhanced delivery systems.
His commitment to improving patient outcomes drives his passion for developing disease-modifying therapeutics that can significantly alter the course of neurological disorders. By combining his clinical insights with a strong foundation in molecular biology and biochemistry, Massimo is at the forefront of advancing therapeutic strategies that hold the potential to transform the lives of individuals affected by CNS conditions. His multifaceted skill set, including expertise in microsurgery and medical devices, positions him as a key leader in the biotechnology sector, dedicated to pioneering solutions that bridge the gap between scientific innovation and clinical application.
Executive Vice President, Therapeutic Strategies at Asklepios BioPharmaceutical, Inc. (AskBio) - CNS Gene Therapy in December 2020 to July 2025
Executive Vice President, Therapeutic Strategies at Brain Neurotherapy Bio, Inc in July 2020 to December 2020
Vice President, Clinical Affairs at Brain Neurotherapy Bio, Inc. in January 2019 to July 2020
Associate Research Scientist WOS - Interventional Neuro Center, Department of Neurosurgery at University of California, San Francisco in August 2012 to August 2019
Assoc Prof in Residence, Departments of Neurology, Neurological Surgery, and Anatomy & Neurobiology at UC Irvine in July 2017 to January 2019
Associate Professor in Residence, Departments of Neurology and Neurological Surgery at UC Irvine in September 2015 to January 2019
Associate Professor in Residence, Department of Neurology at UC Irvine in July 2015 to January 2019
Associate Professor on the Adjunct Track at Georgetown University Medical Center in July 2015 to January 2019
Editorial Board Member at PLOS in October 2013 to October 2015
Associate Professor on the Research Track, Departments of Neurology and Neuroscience at Georgetown University Medical Center in November 2012 to June 2015
Board of Directors, Member at Society for Brain Mapping and Therapeutics in June 2011 to June 2014
Founder/Neurosurgeon/Owner at Massimo S. Fiandaca, MD, PA in July 2001 to December 2012
Sponsored University Associate at Georgetown University Medical Center in September 2012 to October 2012
Associate Research Scientist - Translational NeuroTherapy Center, Department of Neurosurgery at University of California, San Francisco in January 2007 to August 2012
GLG Healthcare Council Consultant at GLG in December 2009 to May 2012
Founder/President/Co-owner at Radiosurgery Consultants, Ltd in July 1998 to August 2001
Assistant Clinical Professor - Department of Neurosurgery at The University of Maryland Medical System in January 1994 to June 2001
Clinical Asst. Professor - Part Time - Department of Neurosurgery at Johns Hopkins Hospital in January 1994 to June 2001
Partner/Co-owner at Lancelotta, Soliman, Jamaris, and Fiandaca, PA in August 1993 to June 2001
Executive MBA - Sellinger School of Business and Management at Loyola University Maryland in January 1999 to January 2001
Chief of Neurosurgical Service at Church Home and Hospital in January 1996 to January 2000
Assistant Professor of Surgery, Division of Neurological Surgery at University of Maryland School of Medicine in July 1991 to August 1993
Co-Medical Director at Gamma Knife Center, University of Maryland in January 1992 to July 1993
Ad-Hoc Grant Reviewer at National Science Foundation in January 1992 to January 1992
Consultant Neurosurgeon at Boston Red Sox in January 1990 to June 1991
Assistant Professor of Surgery, Division of Neurological Surgery at University of Massachusetts Medical School in July 1988 to June 1991
Ad-Hoc Grant Reviewer at BrightFocus Foundation in January 1989 to January 1989
Research Fellow - Neurobiology and Anatomy at University of Rochester Medical Center in January 1987 to January 1988
Collaborative Scientist at Yerkes National Primate Research Center in January 1986 to June 1987
See more
See less
Loyola University Maryland, MBA, January 1999 to January 2001
University of Rochester School of Medicine and Dentistry, Postdoctoral Research Fellow, January 1987 to January 1988
Emory University School of Medicine, Neurological Surgery-Board Eligible, January 1982 to January 1987
Emory University School of Medicine, Intern, January 1981 to January 1982
Oregon Health & Science University, Doctor of Medicine (M.D.), January 1977 to January 1981
Oregon State University, BS, cum laude, January 1973 to January 1977
See more
See less
Neuroscience
Clinical Research
Oncology
Neurology
Medicine
Animal Models
Translational Research
Surgery
Neurosurgery
Clinical Development
Neurodegeneration
Healthcare
Biomarkers
Cancer
Translational Medicine
Lifesciences
Drug Discovery
Stereotactic Radiosurgery
Spine
Clinical Trials
Cell Biology
Traumatic Brain Injury
Medical Education
Entrepreneurship
Gene Therapy
Genetics
Biotechnology
Medical Devices
Pharmacology
Strategic Partnerships
Targeted Drug Delivery
Microsurgery
Bioinformatics
Immunohistochemistry
Stem Cells
Genomics
Biochemistry
In Vivo
Neuroscience Research
Neurosurgical Oncology
Stereotactic Surgery
Biomarker Discovery
Infectious Diseases
Drug Development
Commercialization
Convection Enhanced Delivery
Project Management
Hospitals
Life Sciences
Molecular Biology
See more
See less
What is Massimo Fiandaca email address?
Email Massimo Fiandaca at [email protected] and [email protected]. This email is the most updated Massimo Fiandaca's email found in 2026.
How to contact Massimo Fiandaca?
To contact Massimo Fiandaca send an email to [email protected] or [email protected].
What company does Massimo Fiandaca work for?
Massimo Fiandaca works for Asklepios BioPharmaceutical, Inc. (AskBio) - CNS Gene Therapy
What is Massimo Fiandaca's role at Asklepios BioPharmaceutical, Inc. (AskBio) - CNS Gene Therapy?
Massimo Fiandaca is Executive Vice President, Therapeutic Strategies
What is Massimo Fiandaca's Phone Number?
Massimo Fiandaca's phone (213) ***-*198
What industry does Massimo Fiandaca work in?
Massimo Fiandaca works in the Research industry.
Massimo Fiandaca Email Addresses
Massimo Fiandaca Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Massimo Fiandaca
Head of Financ, Global Oncology and Pharma M&A, BD&L at Bayer
Scientist II at Asklepios BioPharmaceutical, Inc. (AskBio)
Scientist II, Upstream Process Development at Asklepios BioPharmaceutical, Inc. (AskBio)
Fresh Cut Flowers Wholesale Director at PARADISE FLOWERS LLC
Director of Learning and Engagement at Cleveland Museum of Art
Director for Violence Prevention and Response, Flora Stone Mather Center for Women at Case Western Reserve University
Group Category Manager - Technology Procurement at Walgreens Boots Alliance
Manager, Digital Marketing at Los Angeles Philharmonic
Director of Sales and Marketing at Renaissance New York Midtown Hotel
Director, Data Maturity & Strategic Initiatives at Walmart Global Tech
Manager, Pilot Hiring at Sun Country Airlines
Asst. Human Resource Manager at Federal Bureau of Prisons
Senior Community Engagement Manager at DC Comics
Sr Engineering Manager at Stanley Black & Decker, Inc.
Black Information Network - Director of News Operations at iHeartMedia
Regional Manager of Channels, LATAM at Axonius
Senior Site Manager - Rio Tinto at Brunel
Sr. Director,Field Technology Product and Portfolio Management at Adobe
Marketing Systems Manager at Palo Alto Networks
Director of Operations at Lettuce Eat
Director of Operations, Care Management at OhioHealth at OhioHealth
Upstream Packaging Manager-Design at DHL Supply Chain
Manager, IT Infrastructure at Hirsch Pipe and Supply Co., Inc.
Medical Director of Integration at Beacon Health Options
Vice President of Global Data Engineering at phData
Director Of Public Relations at Raising Cane's Chicken Fingers
Director Financial Planning and Analysis at Cardtronics
Talent Acquisition Manager at Brasscraft Mfg.
Show more
Show less